Sunshine Biopharma SBFM Q1 2026 Annual earnings
Reported May 13, 2026 · After market close
Revenue$8.1MMiss by $1.1M
EPS-$0.25Miss by $0.09
Revenue estimate$9.2M
EPS estimate-$0.16
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$8.7M
EPS estimate-$1.20
Versus estimates
Revenue
Diluted EPS
Ask the moment Sunshine Biopharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Sunshine Biopharma report Q1 2026 earnings?
- Sunshine Biopharma (SBFM) reported Q1 2026 earnings on May 13, 2026 after market close.
- What were Sunshine Biopharma's Q1 2026 revenue and EPS?
- Sunshine Biopharma reported revenue of $8.1M and eps of $-0.25 for Q1 2026.
- Did Sunshine Biopharma beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $9.2M by $1.1M. EPS missed the consensus estimate of $-0.16 by $0.09.
- How did Sunshine Biopharma's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 9.1% from $8.9M a year earlier and eps grew 43.2% from $-0.44.
- Where can I find Sunshine Biopharma's Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001683168-26-002644) directly on SEC EDGAR. The filing index links above go to sec.gov.